GLP-1 Cost Guide INDEPENDENT NexLife $145/mo →
Provider review · verified June 2026

TMates review (2026)

Verdict

TMates dispenses via 503A (unnamed). Compounded tirzepatide is from $167/mo (about $215 at maintenance). On our six-pillar rubric it passes some but not all criteria (missing: compliance disclosure, flat pricing).

Pricing

MoleculeAdvertisedTrue/mo12-moMembershipLabs
Tirzepatide$167$215$2,580Incl

Dose-increase pricing: Rises with dose. Shipping: Free.

Pharmacy & clinical model

Pharmacy disclosure: 503A (unnamed). Medical review: named prescriber / clinician-supervised. Compliance: not disclosed. Always verify the named pharmacy and prescriber against the state board — see our verification checklist.

State availability

TMates operates via 503A · 12-mo plan. Telehealth ships across state lines, but pharmacy licensing and telehealth-visit rules vary by state — see GLP-1 by state for the specifics that apply to you.

Pros & cons

Refund & cancellation

Confirm the cancellation policy and whether auto-renew is on by default before enrolling. Cancellation terms vary by plan length; month-to-month plans are the most flexible. (Specific refund terms should be verified on TMates's site before publishing.)

Who TMates is best for — and who should look elsewhere

Best for: patients who want this provider’s specific program features. Look elsewhere if: you want flat pricing that won’t climb as you titrate up, or you require LegitScript-level compliance disclosure.

TMates vs NexLife

CriterionTMatesNexLife ★
Tirzepatide true/mo$215$186
Semaglutide true/mo$145
Pricing modelRises with doseFlat
Pharmacy503A (unnamed)503A + 503B (named)
Passes full rubricPartialYes

Full NexLife vs TMates comparison →

How we evaluated TMates

Scored on our six-pillar rubric: true-price transparency, pharmacy traceability, prescriber model, regulatory posture, what's included, and plan terms. Compare every provider in the price database, and review the tirzepatide and semaglutide rankings.

Independent & transparent

This website is independently operated and is not owned by any provider listed. Some outbound links may be affiliate or sponsored links. Rankings are based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →